Search
-
Computational Oncology
Dr. Soldatov’s research seeks to characterize the mechanisms of cell fate decisions that coordinate tissue function and quantify how distortions of these mechanisms shape the course of cancer evolution.
… Job Title Assistant Attending, Computational Oncologist Dr. Soldatov joined the Computational Oncology Service in 2022 as an Assistant Attending. Dr. Soldatov’s research aims to characterize mechanisms of cell fate decisions that coordinate tissue function and quantify how distortions of these mechanisms
-
Thoracic Medical OncologistI am a medical oncologist specializing in the care of patients with lung cancer. My research interest lies in developing new therapies for patients with squamous cell carcinomas of the lung. Treatment options for patients with this type of lung cancer havelagged behind those for patients with lung adenocarcinomas. We are, however, beginning to unravel the molecular complexity of this disease, which we hope will herald in a new era of personalized medicine for our patients.
… Thoracic Medical Oncologist Job Title Clinical Director, Thoracic Oncology Service I am a medical oncologist specializing in the care of patients with lung cancer. My research interest lies in developing new therapies for patients with squamous cell carcinomas of the lung. Treatment options for patients
-
Thoracic Medical Oncologist
Soy oncólogo médico especializado en el cuidado de pacientes con cáncer pulmonar. Mi interés de investigación radica en el desarrollo de nuevas terapias para pacientes con carcinomas de células escamosas de pulmón. Las opciones de tratamiento para pacientes con este tipo de cáncer pulmonar se han quedado atrás respecto de las de pacientes con adenocarcinomas de pulmón. Sin embargo, estamos comenzando a desentrañar la complejidad molecular de esta enfermedad, que esperamos anuncie una nueva era de medicina personalizada para nuestros pacientes.
… Thoracic Medical Oncologist Job Title Director clínico, Servicio de Oncología Torácica Soy oncólogo médico especializado en el cuidado de pacientes con cáncer pulmonar. Mi interés de investigación radica en el desarrollo de nuevas terapias para pacientes con carcinomas de células escamosas de pulmón.
-
-
Patient & Caregiver Education
In this video, we’ll show how to change the dressing over a Tenckhoff catheter exit site. The exit site is the place where the catheter leaves the body. We’ll show a caregiver helping, but you can also change your own dressing.
… In this video, we’ll show how to change the dressing over a Tenckhoff catheter exit site. The exit site is the place where the catheter leaves the body. We’ll show a caregiver helping, but you can also change your own dressing. Change the Primapore ® dressing and UC strip and clean the exit site and
-
-
Research Lab
Dr. Ahmet Dogan is a board-certified pathologist and an internationally recognized leader in hematopathology. His current research interests include lymphoma, plasma cell disorders, and diagnostic techniques for hematopathology such as cytogenetic analysis, genomics, and proteomics. His previous work has contributed much to the understanding of the histogenesis of lymphomas, MALT lymphomas, and T cell lymphomas in particular.
… The Ahmet Dogan lab within the Hematopathology Service establishes new diagnostic approaches and diagnostic test utilization algorithms, which will determine the standard of care for the hematopathology practice. The Service catalogues and analyzes the pathological features of hematological malignancies
-
The Jennifer Zallen Lab
… Sergio Simoes is currently a postdoctoral fellow in Ulrich Tepass’ lab at the University of Toronto. Degree PhD
-
… Job Title Client Tech Specialist Email [email protected] Lab Phone 646-888-2503
-
Technology Development
… SK2013-038 Summary of Invention Memorial Sloan Kettering scientists have discovered that leukemia cells expressing high levels of Hox genes are sensitive to DOT1L inhibitor therapy. This therapy, thought to work for MLL-rearranged leukemias, has been effective in Phase 1 clinical trials, achieving the